560 related articles for article (PubMed ID: 19507250)
21. Inhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer.
Guigon CJ; Fozzatti L; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2010 Jul; 31(7):1284-91. PubMed ID: 20299527
[TBL] [Abstract][Full Text] [Related]
22. Salt-inducible kinase inhibition sensitizes human acute myeloid leukemia cells to all-trans retinoic acid-induced differentiation.
Zhang XW; Shen X; Long WY; Xiao H; Li FJ; Xing S; Xiong GL; Yu ZY; Cong YW
Int J Hematol; 2021 Feb; 113(2):254-262. PubMed ID: 33074481
[TBL] [Abstract][Full Text] [Related]
23. Post-transcriptional modulation of C/EBPα prompts monocytic differentiation and apoptosis in acute myelomonocytic leukaemia cells.
Yoshida H; Imamura T; Fujiki A; Hirashima Y; Miyachi M; Inukai T; Hosoi H
Leuk Res; 2012 Jun; 36(6):735-41. PubMed ID: 22349414
[TBL] [Abstract][Full Text] [Related]
24. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis.
Ying M; Zhou X; Zhong L; Lin N; Jing H; Luo P; Yang X; Song H; Yang B; He Q
Mol Cancer Ther; 2013 Feb; 12(2):195-206. PubMed ID: 23243061
[TBL] [Abstract][Full Text] [Related]
25. 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.
Asou H; Koike M; Elstner E; Cambell M; Le J; Uskokovic MR; Kamada N; Koeffler HP
Blood; 1998 Oct; 92(7):2441-9. PubMed ID: 9746784
[TBL] [Abstract][Full Text] [Related]
26. Combined inhibition of PI3K and mTOR exerts synergistic antiproliferative effect, but diminishes differentiative properties of rapamycin in acute myeloid leukemia cells.
Mise J; Dembitz V; Banfic H; Visnjic D
Pathol Oncol Res; 2011 Sep; 17(3):645-56. PubMed ID: 21336564
[TBL] [Abstract][Full Text] [Related]
27. Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor.
Rashid A; Duan X; Gao F; Yang M; Yen A
Cell Signal; 2020 Jul; 71():109555. PubMed ID: 32032659
[TBL] [Abstract][Full Text] [Related]
28. Rosmarinic acid potentiates ATRA-induced macrophage differentiation in acute promyelocytic leukemia NB4 cells.
Heo SK; Noh EK; Yoon DJ; Jo JC; Koh S; Baek JH; Park JH; Min YJ; Kim H
Eur J Pharmacol; 2015 Jan; 747():36-44. PubMed ID: 25481858
[TBL] [Abstract][Full Text] [Related]
29. Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia.
Chapuis N; Tamburini J; Green AS; Vignon C; Bardet V; Neyret A; Pannetier M; Willems L; Park S; Macone A; Maira SM; Ifrah N; Dreyfus F; Herault O; Lacombe C; Mayeux P; Bouscary D
Clin Cancer Res; 2010 Nov; 16(22):5424-35. PubMed ID: 20884625
[TBL] [Abstract][Full Text] [Related]
30. PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells.
Ikezoe T; Chen S; Saito T; Asou H; Kyo T; Tanosaki S; Heber D; Taguchi H; Koeffler HP
Int J Oncol; 2003 Oct; 23(4):1203-11. PubMed ID: 12964005
[TBL] [Abstract][Full Text] [Related]
31. Complex regulation of CDKs and G1 arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells.
Shimizu T; Awai N; Takeda K
Oncogene; 2000 Sep; 19(40):4640-6. PubMed ID: 11030153
[TBL] [Abstract][Full Text] [Related]
32. Emodin enhances ATRA-induced differentiation and induces apoptosis in acute myeloid leukemia cells.
Chen Y; Li J; Hu J; Zheng J; Zheng Z; Liu T; Lin Z; Lin M
Int J Oncol; 2014 Nov; 45(5):2076-84. PubMed ID: 25174432
[TBL] [Abstract][Full Text] [Related]
33. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
34. RAD 001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia.
Mancini M; Petta S; Martinelli G; Barbieri E; Santucci MA
J Cell Biochem; 2010 Feb; 109(2):320-8. PubMed ID: 20014066
[TBL] [Abstract][Full Text] [Related]
35. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
[TBL] [Abstract][Full Text] [Related]
36. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract][Full Text] [Related]
37. RARγ-C-Fos-PPARγ2 signaling rather than ROS generation is critical for all-trans retinoic acid-inhibited adipocyte differentiation.
Wang X; Yang P; Liu J; Wu H; Yu W; Zhang T; Fu H; Liu Y; Hai C
Biochimie; 2014 Nov; 106():121-30. PubMed ID: 25173565
[TBL] [Abstract][Full Text] [Related]
38. Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.
Chen Q; Ross AC
Exp Cell Res; 2004 Jul; 297(1):68-81. PubMed ID: 15194426
[TBL] [Abstract][Full Text] [Related]
39. Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001.
Kuo SH; Hsu CH; Chen LT; Lu YS; Lin CH; Yeh PY; Jeng HJ; Gao M; Yeh KH; Cheng AL
Eur J Cancer; 2011 May; 47(8):1244-57. PubMed ID: 21334199
[TBL] [Abstract][Full Text] [Related]
40. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells.
Zhang R; Banik NL; Ray SK
Cancer Chemother Pharmacol; 2008 Aug; 62(3):407-16. PubMed ID: 17960384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
